Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the four analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month […]
Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the four analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month […]
